https://www.wikidoc.org/api.php?action=feedrecentchanges&days=7&feedformat=atom&hidebots=1&hideminor=1&hidemyself=1&target=Category%3ACS1_maint%3A_Explicit_use_of_et_al.&urlversion=1
wikidoc - Changes related to "Category:CS1 maint: Explicit use of et al." [en]
2026-05-11T18:30:36Z
Related changes
MediaWiki 1.45.1
https://www.wikidoc.org/index.php?title=Hypertensive_crisis&diff=1744192&oldid=1737139
Hypertensive crisis
2026-05-11T18:00:16Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 18:00, 11 May 2026</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l6">Line 6:</td>
<td colspan="2" class="diff-lineno">Line 6:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|}</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{SI}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{SI}}</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>{{CMG}}; {{AE}} {{AN}}</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>{{CMG}}; {{AE}} {{AN<ins style="font-weight: bold; text-decoration: none;">}} {{HMA</ins>}}</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{SK}} Hypertensive emergency; hypertensive urgency; severe hypertension</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{SK}} Hypertensive emergency; hypertensive urgency; severe hypertension</div></td></tr>
</table>
Mohammad Ahmed
https://www.wikidoc.org/index.php?title=Heart_failure_resident_survival_guide&diff=1744163&oldid=1744000
Heart failure resident survival guide
2026-05-06T22:22:38Z
<p></p>
<a href="https://www.wikidoc.org/index.php?title=Heart_failure_resident_survival_guide&diff=1744163&oldid=1744000">Show changes</a>
Joseph Nasr
https://www.wikidoc.org/index.php?title=Congestive_heart_failure_Management_of_Acute_heart_failure&diff=1744162&oldid=1743970
Congestive heart failure Management of Acute heart failure
2026-05-06T22:03:50Z
<p></p>
<a href="https://www.wikidoc.org/index.php?title=Congestive_heart_failure_Management_of_Acute_heart_failure&diff=1744162&oldid=1743970">Show changes</a>
Joseph Nasr
https://www.wikidoc.org/index.php?title=Ischemic_stroke_medical_therapy&diff=1744153&oldid=1744130
Ischemic stroke medical therapy
2026-05-05T16:05:16Z
<p></p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 16:05, 5 May 2026</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l4">Line 4:</td>
<td colspan="2" class="diff-lineno">Line 4:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Overview==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Overview==</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Acute ischemic stroke therapy is primarily directed to rapid reperfusion with intravenous thrombolysis (alteplase or tenecteplase) in eligible patients and endovascular thrombectomy (EVT) in eligible patients with large vessel occlusion (LVO); these treatments should be considered in parallel and should not delay each other.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Acute ischemic stroke therapy is primarily directed to rapid reperfusion with intravenous thrombolysis (alteplase or tenecteplase) in eligible patients and endovascular thrombectomy (EVT) in eligible patients with large vessel occlusion (LVO); these treatments should be considered in parallel and should not delay each other.<ins style="font-weight: bold; text-decoration: none;"><ref name="pmid41582814">{{cite journal |vauthors=Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, Pérez de la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S |title=2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association |journal=Stroke |volume= |issue= |pages= |date=January 2026 |pmid=41582814 |doi=10.1161/STR.0000000000000513 |url=}}</ref></ins></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Antiplatelet therapy (usually aspirin) is recommended within 24–48 hours after onset in most patients who are not receiving IV thrombolysis, and is generally delayed until 24 hours after thrombolysis.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Antiplatelet therapy (usually aspirin) is recommended within 24–48 hours after onset in most patients who are not receiving IV thrombolysis, and is generally delayed until 24 hours after thrombolysis.<ins style="font-weight: bold; text-decoration: none;"><ref name="pmid41582814">{{cite journal |vauthors=Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, Pérez de la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S |title=2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association |journal=Stroke |volume= |issue= |pages= |date=January 2026 |pmid=41582814 |doi=10.1161/STR.0000000000000513 |url=}}</ref></ins></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>Secondary prevention includes antiplatelets or anticoagulation depending on etiology (eg, atrial fibrillation), lipid-lowering therapy, and risk-factor management.</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>Secondary prevention includes antiplatelets or anticoagulation depending on etiology (eg, atrial fibrillation), lipid-lowering therapy, and risk-factor management.<ins style="font-weight: bold; text-decoration: none;"><ref name="pmid41582814">{{cite journal |vauthors=Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, Pérez de la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S |title=2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association |journal=Stroke |volume= |issue= |pages= |date=January 2026 |pmid=41582814 |doi=10.1161/STR.0000000000000513 |url=}}</ref></ins></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Medical Therapy==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>==Medical Therapy==</div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">The reported cases </del>of <del style="font-weight: bold; text-decoration: none;">treatment for [[</del>COVID-<del style="font-weight: bold; text-decoration: none;">19]]-associated [[</del>stroke<del style="font-weight: bold; text-decoration: none;">]] have followed the same guidelines as patients with no [[COVID-19]] infection. The following recommendations are mainly based on the current guidelines of management for </del>stroke <del style="font-weight: bold; text-decoration: none;">of the AHA 2019.</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins style="font-weight: bold; text-decoration: none;">Treatment </ins>of COVID-<ins style="font-weight: bold; text-decoration: none;">19–associated ischemic </ins>stroke <ins style="font-weight: bold; text-decoration: none;">generally follows standard acute ischemic </ins>stroke <ins style="font-weight: bold; text-decoration: none;">pathways</ins>.<ref name="<ins style="font-weight: bold; text-decoration: none;">pmid41582814</ins>">{{cite journal |<ins style="font-weight: bold; text-decoration: none;">vauthors</ins>=<ins style="font-weight: bold; text-decoration: none;">Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, </ins>Menon B<ins style="font-weight: bold; text-decoration: none;">, Mistry EA, Park S, Parker S, Pérez de la Ossa N, Reeves </ins>M<ins style="font-weight: bold; text-decoration: none;">, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S </ins>|<ins style="font-weight: bold; text-decoration: none;">title</ins>=<ins style="font-weight: bold; text-decoration: none;">2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association </ins>|<ins style="font-weight: bold; text-decoration: none;">journal</ins>=<ins style="font-weight: bold; text-decoration: none;">Stroke </ins>|<ins style="font-weight: bold; text-decoration: none;">volume</ins>= |<ins style="font-weight: bold; text-decoration: none;">issue</ins>= |<ins style="font-weight: bold; text-decoration: none;">pages</ins>= |<ins style="font-weight: bold; text-decoration: none;">date</ins>=<ins style="font-weight: bold; text-decoration: none;">January 2026 </ins>|<ins style="font-weight: bold; text-decoration: none;">pmid</ins>=<ins style="font-weight: bold; text-decoration: none;">41582814 </ins>|<ins style="font-weight: bold; text-decoration: none;">doi</ins>=<ins style="font-weight: bold; text-decoration: none;">10.1161/STR</ins>.<ins style="font-weight: bold; text-decoration: none;">0000000000000513 </ins>|<ins style="font-weight: bold; text-decoration: none;">url</ins>=<ins style="font-weight: bold; text-decoration: none;">}}</ref></ins></div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">*[[Alteplase|IV alteplase]] is always preferred over mechanical [[thrombectomy]] when there are no contraindications</del>.<ref name="<del style="font-weight: bold; text-decoration: none;">SaverGoyal2016</del>">{{cite journal|<del style="font-weight: bold; text-decoration: none;">last1=Saver|first1=Jeffrey L.|last2=Goyal|first2=Mayank|last3=van der Lugt|first3=Aad|last4</del>=Menon<del style="font-weight: bold; text-decoration: none;">|first4=Bijoy K.|last5=Majoie|first5=Charles </del>B<del style="font-weight: bold; text-decoration: none;">. L. </del>M<del style="font-weight: bold; text-decoration: none;">.</del>|<del style="font-weight: bold; text-decoration: none;">last6</del>=<del style="font-weight: bold; text-decoration: none;">Dippel</del>|<del style="font-weight: bold; text-decoration: none;">first6</del>=<del style="font-weight: bold; text-decoration: none;">Diederik W.</del>|<del style="font-weight: bold; text-decoration: none;">last7</del>=<del style="font-weight: bold; text-decoration: none;">Campbell</del>|<del style="font-weight: bold; text-decoration: none;">first7</del>=<del style="font-weight: bold; text-decoration: none;">Bruce C.</del>|<del style="font-weight: bold; text-decoration: none;">last8</del>=<del style="font-weight: bold; text-decoration: none;">Nogueira</del>|<del style="font-weight: bold; text-decoration: none;">first8</del>=<del style="font-weight: bold; text-decoration: none;">Raul G.</del>|<del style="font-weight: bold; text-decoration: none;">last9</del>=<del style="font-weight: bold; text-decoration: none;">Demchuk</del>|<del style="font-weight: bold; text-decoration: none;">first9</del>=<del style="font-weight: bold; text-decoration: none;">Andrew M</del>.|<del style="font-weight: bold; text-decoration: none;">last10</del>=<del style="font-weight: bold; text-decoration: none;">Tomasello|first10=Alejandro|last11=Cardona|first11=Pere|last12=Devlin|first12=Thomas G</del>.<del style="font-weight: bold; text-decoration: none;">|last13</del>=<del style="font-weight: bold; text-decoration: none;">Frei</del>|<del style="font-weight: bold; text-decoration: none;">first13</del>=<del style="font-weight: bold; text-decoration: none;">Donald F.|last14=du Mesnil </del>de <del style="font-weight: bold; text-decoration: none;">Rochemont</del>|<del style="font-weight: bold; text-decoration: none;">first14</del>=<del style="font-weight: bold; text-decoration: none;">Richard|last15=Berkhemer|first15=Olvert </del>A<del style="font-weight: bold; text-decoration: none;">.</del>|<del style="font-weight: bold; text-decoration: none;">last16</del>=<del style="font-weight: bold; text-decoration: none;">Jovin</del>|<del style="font-weight: bold; text-decoration: none;">first16=Tudor G.|last17</del>=<del style="font-weight: bold; text-decoration: none;">Siddiqui</del>|<del style="font-weight: bold; text-decoration: none;">first17</del>=<del style="font-weight: bold; text-decoration: none;">Adnan H.</del>|<del style="font-weight: bold; text-decoration: none;">last18</del>=<del style="font-weight: bold; text-decoration: none;">van Zwam</del>|<del style="font-weight: bold; text-decoration: none;">first18</del>=<del style="font-weight: bold; text-decoration: none;">Wim H.</del>|<del style="font-weight: bold; text-decoration: none;">last19</del>=<del style="font-weight: bold; text-decoration: none;">Davis</del>|<del style="font-weight: bold; text-decoration: none;">first19</del>=<del style="font-weight: bold; text-decoration: none;">Stephen M</del>.<del style="font-weight: bold; text-decoration: none;">|last20=Castaño|first20=Carlos|last21=Sapkota|first21=Biggya L</del>.|<del style="font-weight: bold; text-decoration: none;">last22</del>=<del style="font-weight: bold; text-decoration: none;">Fransen|first22=Puck S</del>.<del style="font-weight: bold; text-decoration: none;">|last23</del>=<del style="font-weight: bold; text-decoration: none;">Molina</del>|<del style="font-weight: bold; text-decoration: none;">first23</del>=<del style="font-weight: bold; text-decoration: none;">Carlos</del>|<del style="font-weight: bold; text-decoration: none;">last24</del>=<del style="font-weight: bold; text-decoration: none;">van Oostenbrugge</del>|<del style="font-weight: bold; text-decoration: none;">first24</del>=<del style="font-weight: bold; text-decoration: none;">Robert J.</del>|<del style="font-weight: bold; text-decoration: none;">last25</del>=<del style="font-weight: bold; text-decoration: none;">Chamorro</del>|<del style="font-weight: bold; text-decoration: none;">first25</del>=<del style="font-weight: bold; text-decoration: none;">Ángel</del>|<del style="font-weight: bold; text-decoration: none;">last26</del>=<del style="font-weight: bold; text-decoration: none;">Lingsma</del>|<del style="font-weight: bold; text-decoration: none;">first26</del>=<del style="font-weight: bold; text-decoration: none;">Hester</del>|<del style="font-weight: bold; text-decoration: none;">last27</del>=<del style="font-weight: bold; text-decoration: none;">Silver</del>|<del style="font-weight: bold; text-decoration: none;">first27</del>=<del style="font-weight: bold; text-decoration: none;">Frank L</del>.|<del style="font-weight: bold; text-decoration: none;">last28</del>=<del style="font-weight: bold; text-decoration: none;">Donnan</del>|<del style="font-weight: bold; text-decoration: none;">first28</del>=<del style="font-weight: bold; text-decoration: none;">Geoffrey A.</del>|<del style="font-weight: bold; text-decoration: none;">last29</del>=<del style="font-weight: bold; text-decoration: none;">Shuaib</del>|<del style="font-weight: bold; text-decoration: none;">first29</del>=<del style="font-weight: bold; text-decoration: none;">Ashfaq</del>|<del style="font-weight: bold; text-decoration: none;">last30</del>=<del style="font-weight: bold; text-decoration: none;">Brown</del>|<del style="font-weight: bold; text-decoration: none;">first30</del>=<del style="font-weight: bold; text-decoration: none;">Scott</del>|<del style="font-weight: bold; text-decoration: none;">last31</del>=<del style="font-weight: bold; text-decoration: none;">Stouch</del>|<del style="font-weight: bold; text-decoration: none;">first31</del>=<del style="font-weight: bold; text-decoration: none;">Bruce</del>|<del style="font-weight: bold; text-decoration: none;">last32</del>=<del style="font-weight: bold; text-decoration: none;">Mitchell</del>|<del style="font-weight: bold; text-decoration: none;">first32</del>=<del style="font-weight: bold; text-decoration: none;">Peter J</del>.|<del style="font-weight: bold; text-decoration: none;">last33</del>=<del style="font-weight: bold; text-decoration: none;">Davalos|first33</del>=<del style="font-weight: bold; text-decoration: none;">Antoni</del>|<del style="font-weight: bold; text-decoration: none;">last34</del>=<del style="font-weight: bold; text-decoration: none;">Roos|first34=Yvo </del>B<del style="font-weight: bold; text-decoration: none;">. W. </del>E<del style="font-weight: bold; text-decoration: none;">. </del>M<del style="font-weight: bold; text-decoration: none;">.|last35=Hill|first35=Michael D.</del>|title=<del style="font-weight: bold; text-decoration: none;">Time to Treatment With Endovascular </del>Thrombectomy <del style="font-weight: bold; text-decoration: none;">and Outcomes From Ischemic </del>Stroke<del style="font-weight: bold; text-decoration: none;">: A Meta-analysis</del>|journal=<del style="font-weight: bold; text-decoration: none;">JAMA</del>|volume=<del style="font-weight: bold; text-decoration: none;">316</del>|issue=<del style="font-weight: bold; text-decoration: none;">12</del>|<del style="font-weight: bold; text-decoration: none;">year</del>=<del style="font-weight: bold; text-decoration: none;">2016</del>|<del style="font-weight: bold; text-decoration: none;">pages</del>=<del style="font-weight: bold; text-decoration: none;">1279</del>|<del style="font-weight: bold; text-decoration: none;">issn</del>=<del style="font-weight: bold; text-decoration: none;">0098-7484</del>|doi=10.<del style="font-weight: bold; text-decoration: none;">1001</del>/<del style="font-weight: bold; text-decoration: none;">jama.2016.13647</del>}}</ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*In patients with suspected or confirmed LVO, evaluation for EVT should occur urgently, and IV thrombolysis should be given when eligible without delaying EVT</ins>.<ins style="font-weight: bold; text-decoration: none;"><ref name</ins>=<ins style="font-weight: bold; text-decoration: none;">"pmid41582814">{{cite journal </ins>|<ins style="font-weight: bold; text-decoration: none;">vauthors</ins>=<ins style="font-weight: bold; text-decoration: none;">Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, Chapman S, Czap AL, Dumitrascu OM, Ishida K, Jadhav AP, Johnson B, Johnston KC, Khatri P, Kimberly WT, Lee VH, Leslie-Mazwi TM, Mac Grory B, Madsen TE, Menon B, Mistry EA, Park S, Parker S, Pérez </ins>de <ins style="font-weight: bold; text-decoration: none;">la Ossa N, Reeves M, Saiz T, Scott PA, Schwartzberg D, Sheth SA, Sporns PB, Times S, Tjoumakaris S, Wolfe SQ, Yaghi S </ins>|<ins style="font-weight: bold; text-decoration: none;">title</ins>=<ins style="font-weight: bold; text-decoration: none;">2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: </ins>A <ins style="font-weight: bold; text-decoration: none;">Guideline From the American Heart Association/American Stroke Association </ins>|<ins style="font-weight: bold; text-decoration: none;">journal</ins>=<ins style="font-weight: bold; text-decoration: none;">Stroke </ins>|<ins style="font-weight: bold; text-decoration: none;">volume</ins>= |<ins style="font-weight: bold; text-decoration: none;">issue</ins>= |<ins style="font-weight: bold; text-decoration: none;">pages</ins>= |<ins style="font-weight: bold; text-decoration: none;">date</ins>=<ins style="font-weight: bold; text-decoration: none;">January 2026 </ins>|<ins style="font-weight: bold; text-decoration: none;">pmid</ins>=<ins style="font-weight: bold; text-decoration: none;">41582814 </ins>|<ins style="font-weight: bold; text-decoration: none;">doi</ins>=<ins style="font-weight: bold; text-decoration: none;">10</ins>.<ins style="font-weight: bold; text-decoration: none;">1161/STR</ins>.<ins style="font-weight: bold; text-decoration: none;">0000000000000513 </ins>|<ins style="font-weight: bold; text-decoration: none;">url</ins>=<ins style="font-weight: bold; text-decoration: none;">}}</ref></ins></div></td></tr>
<tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">*EVT indications include appropriately selected patients within 0–6 hours, and in selected patients within 6–24 hours based on imaging/clinical criteria; recent randomized trials also support EVT in selected large ischemic core anterior circulation strokes</ins>.<ins style="font-weight: bold; text-decoration: none;"><ref name</ins>=<ins style="font-weight: bold; text-decoration: none;">"pmid38759664">{{cite journal </ins>|<ins style="font-weight: bold; text-decoration: none;">vauthors</ins>=<ins style="font-weight: bold; text-decoration: none;">Hilkens NA, Casolla B, Leung TW, de Leeuw FE </ins>|<ins style="font-weight: bold; text-decoration: none;">title</ins>=<ins style="font-weight: bold; text-decoration: none;">Stroke </ins>|<ins style="font-weight: bold; text-decoration: none;">journal</ins>=<ins style="font-weight: bold; text-decoration: none;">Lancet </ins>|<ins style="font-weight: bold; text-decoration: none;">volume</ins>=<ins style="font-weight: bold; text-decoration: none;">403 </ins>|<ins style="font-weight: bold; text-decoration: none;">issue</ins>=<ins style="font-weight: bold; text-decoration: none;">10446 </ins>|<ins style="font-weight: bold; text-decoration: none;">pages</ins>=<ins style="font-weight: bold; text-decoration: none;">2820–2836 </ins>|<ins style="font-weight: bold; text-decoration: none;">date</ins>=<ins style="font-weight: bold; text-decoration: none;">June 2024 </ins>|<ins style="font-weight: bold; text-decoration: none;">pmid</ins>=<ins style="font-weight: bold; text-decoration: none;">38759664 </ins>|<ins style="font-weight: bold; text-decoration: none;">doi</ins>=<ins style="font-weight: bold; text-decoration: none;">10</ins>.<ins style="font-weight: bold; text-decoration: none;">1016/S0140-6736(24)00642-1 </ins>|<ins style="font-weight: bold; text-decoration: none;">url</ins>=<ins style="font-weight: bold; text-decoration: none;">}}</ref> <ref name="pmid38265667">{{cite journal </ins>|<ins style="font-weight: bold; text-decoration: none;">vauthors</ins>= |<ins style="font-weight: bold; text-decoration: none;">title</ins>=<ins style="font-weight: bold; text-decoration: none;">Trial of Endovascular Thrombectomy for Large Ischemic Strokes </ins>|<ins style="font-weight: bold; text-decoration: none;">journal</ins>=<ins style="font-weight: bold; text-decoration: none;">N Engl J Med </ins>|<ins style="font-weight: bold; text-decoration: none;">volume</ins>=<ins style="font-weight: bold; text-decoration: none;">390 </ins>|<ins style="font-weight: bold; text-decoration: none;">issue</ins>=<ins style="font-weight: bold; text-decoration: none;">4 </ins>|<ins style="font-weight: bold; text-decoration: none;">pages</ins>=<ins style="font-weight: bold; text-decoration: none;">388 </ins>|<ins style="font-weight: bold; text-decoration: none;">date</ins>=<ins style="font-weight: bold; text-decoration: none;">January 2024 </ins>|<ins style="font-weight: bold; text-decoration: none;">pmid</ins>=<ins style="font-weight: bold; text-decoration: none;">38265667 </ins>|<ins style="font-weight: bold; text-decoration: none;">doi</ins>=<ins style="font-weight: bold; text-decoration: none;">10</ins>.<ins style="font-weight: bold; text-decoration: none;">1056/NEJMx230009 </ins>|<ins style="font-weight: bold; text-decoration: none;">url</ins>=<ins style="font-weight: bold; text-decoration: none;">}}</ref> <ref name</ins>=<ins style="font-weight: bold; text-decoration: none;">"pmid38718358">{{cite journal </ins>|<ins style="font-weight: bold; text-decoration: none;">vauthors</ins>=<ins style="font-weight: bold; text-decoration: none;">Costalat V, Jovin TG, Albucher JF, Cognard C, Henon H, Nouri N, Gory B, Richard S, Marnat G, Sibon I, Di Maria F, Annan M, Boulouis G, Cardona P, Obadia M, Piotin M, Bourcier R, Guillon </ins>B<ins style="font-weight: bold; text-decoration: none;">, Godard S, Pasco-Papon A, Eker OF, Cho TH, Turc G, Naggara O, Velasco S, Lamy M, Clarençon F, Alamowitch S, Renu A, Suissa L, Brunel H, Gentric JC, Timsit S, Lamy C, Chivot C, Macian-Montoro F, Mounayer C, Ozkul-Wermester O, Papagiannaki C, Wolff V, Pop R, Ferrier A, Chabert E, Ricolfi F, Béjot Y, Lopez-Cancio E, Vega P, Spelle L, Denier C, Millán M, Arenillas JF, Mazighi M, Houdart </ins>E<ins style="font-weight: bold; text-decoration: none;">, Del Mar Freijo </ins>M<ins style="font-weight: bold; text-decoration: none;">, Duhamel A, Sanossian N, Liebeskind DS, Labreuche J, Lapergue B, Arquizan C </ins>|title=<ins style="font-weight: bold; text-decoration: none;">Trial of </ins>Thrombectomy <ins style="font-weight: bold; text-decoration: none;">for </ins>Stroke <ins style="font-weight: bold; text-decoration: none;">with a Large Infarct of Unrestricted Size </ins>|journal=<ins style="font-weight: bold; text-decoration: none;">N Engl J Med </ins>|volume=<ins style="font-weight: bold; text-decoration: none;">390 </ins>|issue=<ins style="font-weight: bold; text-decoration: none;">18 </ins>|<ins style="font-weight: bold; text-decoration: none;">pages</ins>=<ins style="font-weight: bold; text-decoration: none;">1677–1689 </ins>|<ins style="font-weight: bold; text-decoration: none;">date</ins>=<ins style="font-weight: bold; text-decoration: none;">May 2024 </ins>|<ins style="font-weight: bold; text-decoration: none;">pmid</ins>=<ins style="font-weight: bold; text-decoration: none;">38718358 </ins>|doi=10.<ins style="font-weight: bold; text-decoration: none;">1056</ins>/<ins style="font-weight: bold; text-decoration: none;">NEJMoa2314063 |url=</ins>}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*The usefulness of [[anticoagulants]] such as [[thrombin]] inhibitors ([[dabigatran]]) and [[factor Xa]] inhibitors ([[rivaroxaban]], [[apixaban]], [[edoxaban]]) is not well established in the acute setting of [[stroke]].<ref name="GioiaKate2016">{{cite journal|last1=Gioia|first1=Laura C.|last2=Kate|first2=Mahesh|last3=Sivakumar|first3=Leka|last4=Hussain|first4=Dulara|last5=Kalashyan|first5=Hayrapet|last6=Buck|first6=Brian|last7=Bussiere|first7=Miguel|last8=Jeerakathil|first8=Thomas|last9=Shuaib|first9=Ashfaq|last10=Emery|first10=Derek|last11=Butcher|first11=Ken|title=Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation|journal=Stroke|volume=47|issue=7|year=2016|pages=1917–1919|issn=0039-2499|doi=10.1161/STROKEAHA.116.013491}}</ref></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*The usefulness of [[anticoagulants]] such as [[thrombin]] inhibitors ([[dabigatran]]) and [[factor Xa]] inhibitors ([[rivaroxaban]], [[apixaban]], [[edoxaban]]) is not well established in the acute setting of [[stroke]].<ref name="GioiaKate2016">{{cite journal|last1=Gioia|first1=Laura C.|last2=Kate|first2=Mahesh|last3=Sivakumar|first3=Leka|last4=Hussain|first4=Dulara|last5=Kalashyan|first5=Hayrapet|last6=Buck|first6=Brian|last7=Bussiere|first7=Miguel|last8=Jeerakathil|first8=Thomas|last9=Shuaib|first9=Ashfaq|last10=Emery|first10=Derek|last11=Butcher|first11=Ken|title=Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation|journal=Stroke|volume=47|issue=7|year=2016|pages=1917–1919|issn=0039-2499|doi=10.1161/STROKEAHA.116.013491}}</ref></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*The use of [[thrombolysis]] via ultrasound waves concomitant to [[Fibrinolysis|IV fibrinolysis]] is not recommended.<ref name="NacuKvistad2017">{{cite journal|last1=Nacu|first1=Aliona|last2=Kvistad|first2=Christopher E.|last3=Naess|first3=Halvor|last4=Øygarden|first4=Halvor|last5=Logallo|first5=Nicola|last6=Assmus|first6=Jörg|last7=Waje-Andreassen|first7=Ulrike|last8=Kurz|first8=Kathinka D.|last9=Neckelmann|first9=Gesche|last10=Thomassen|first10=Lars|title=NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study)|journal=Stroke|volume=48|issue=2|year=2017|pages=335–341|issn=0039-2499|doi=10.1161/STROKEAHA.116.014644}}</ref></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*The use of [[thrombolysis]] via ultrasound waves concomitant to [[Fibrinolysis|IV fibrinolysis]] is not recommended.<ref name="NacuKvistad2017">{{cite journal|last1=Nacu|first1=Aliona|last2=Kvistad|first2=Christopher E.|last3=Naess|first3=Halvor|last4=Øygarden|first4=Halvor|last5=Logallo|first5=Nicola|last6=Assmus|first6=Jörg|last7=Waje-Andreassen|first7=Ulrike|last8=Kurz|first8=Kathinka D.|last9=Neckelmann|first9=Gesche|last10=Thomassen|first10=Lars|title=NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study)|journal=Stroke|volume=48|issue=2|year=2017|pages=335–341|issn=0039-2499|doi=10.1161/STROKEAHA.116.014644}}</ref></div></td></tr>
</table>
Hasnain Ali